Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MME | P08473 | 5/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ECE1 | P42892 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.43 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6688986 | 0.96 | CTSL (0.55) | CTSLALDH1A1TSHRMMECYP1A2 | |
| SCHEMBL265813 | 0.86 | CTSL (0.67) | CTSLALDH1A1TSHRMMECYP1A2 | |
| SCHEMBL1958029 | 0.81 | MME (0.50) | CTSLALDH1A1MMECYP1A2CYP3A4 | |
| SCHEMBL6664470 | 0.80 | CTSL (0.46) | CTSLALDH1A1TSHRMMEACE | |
| SCHEMBL1957422 | 0.78 | ALDH1A1 (0.52) | CTSLALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1955086 | 0.78 | ALDH1A1 (0.52) | CTSLALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL27642499 | 0.78 | ALDH1A1 (0.52) | CTSLALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL25218054 | 0.77 | MME (0.48) | CTSLALDH1A1MMEACEMEN1 | |
| SCHEMBL6036874 | 0.77 | SMN1; SMN2 (0.46) | ALDH1A1KMT2AHPGDSMN1; SMN2 | |
| SCHEMBL29385523 | 0.77 | CTSL (0.51) | CTSLALDH1A1MMEACEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090258387-A1 | BIOACTIVE WHEY PROTEIN HYDROLYSATE | SCHLOTHAUER RALF-CHRISTIAN | 2009-10-15 | — | — | US | disclosed |
| US-20080292750-A1 | Method of Preparing a Food Ingredient and Food Product Having Angiotensin-I-Converting Enzyme Inhibiting Properties and Products Thus Obtained | CAMOINA NEDERLAND HOLDING B.V. (NL) | 2008-11-27 | — | — | US | disclosed |
| US-20080032915-A1 | Cysteine Rich Peptides for Improving Thiol Homeostasis | CAMPINA NEDERLAND HOLDING B.V. (NL) | 2008-02-07 | — | — | US | disclosed |
| EP-1727440-A1 | METHOD OF PREPARING A FOOD INGREDIENT AND FOOD PRODUCT HAVING ANGIOTENSIN-I-CONVERTING ENZYME INHIBITING PROPERTIES AND PRODUCTS THUS OBTAINED | Campina Nederland Holding B.V. (NL) | 2006-12-06 | — | — | EP | disclosed |
| EP-1715881-A1 | CYSTEINE RICH PEPTIDES FOR IMPROVING THIOL HOMEOSTASIS | Campina Nederland Holding B.V. (NL) | 2006-11-02 | — | — | EP | disclosed |
| CN-1693878-A | Method and kit for scaling investigating angiotensin aminopherase | ZHEJIANG YAKE PHARMACEUTICAL C (CN) | 2005-11-09 | — | — | CN | disclosed |
| WO-2005096847-A1 | METHOD OF PREPARING A FOOD INGREDIENT AND FOOD PRODUCT HAVING ANGIOTENSIN-I-CONVERTING ENZYME INHIBITING PROPERTIES AND PRODUCTS THUS OBTAINED | CAMPINA NEDERLAND HOLDING B.V. (NL) | 2005-10-20 | — | — | WO | disclosed |
| WO-2005077400-A1 | CYSTEINE RICH PEPTIDES FOR IMPROVING THIOL HOMEOSTASIS | CAMPINA NEDERLAND HOLDING B.V. (NL) | 2005-08-25 | — | — | WO | disclosed |
| US-20050164340-A1 | Bioactive whey protein hydrolysate | SCHLOTHAUER RALF-CHRISTIAN (NZ) | 2005-07-28 | — | — | US | disclosed |
| US-6919314-B1 | Bioactive whey protein hydrolysate | NEW ZEALAND DAIRY BOARD (NZ) | 2005-07-19 | — | — | US | disclosed |
| WO-1997024342-A1 | THIOL DERIVATIVES WITH METALLOPEPTIDASE INHIBITORY ACTIVITY | ZAMBON GROUP S.P.A. (IT) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997019102-A1 | PHOSPHONIC ACID DERIVATIVES WITH METALLOPEPTIDASE INHIBITORY ACTIVITY | ZAMBON GROUP S.P.A. (IT) | 1997-05-29 | — | — | WO | disclosed |
| WO-1997000261-A1 | PHOSPHINIC ACID DERIVATIVES WITH METALLOPEPTIDASE INHIBITORY ACTIVITY | ZAMBON GROUP S.P.A. (IT) | 1997-01-03 | — | — | WO | disclosed |
| WO-1994023730-A1 | METHOD OF TREATING HEPATITIS B INFECTION | KREMERS-URBAN COMPANY (US) | 1994-10-27 | — | — | WO | disclosed |
| US-5334395-A | Using a polypeptide | KREMERS-URBAN COMPANY (US) | 1994-08-02 | — | — | US | disclosed |
| US-5316775-A | Mammalian liver extract | KREMERS-URBAN COMPANY (US) | 1994-05-31 | — | — | US | disclosed |
| WO-1994004170-A1 | METHOD OF TREATING EPSTEIN-BARR VIRUS INFECTION | KREMERS-URBAN COMPANY (US) | 1994-03-03 | — | — | WO | disclosed |
| US-5284664-A | Administering mammalian liver extract | KREMERS-URBAN COMPANY (US) | 1994-02-08 | — | — | US | disclosed |
| EP-0554887-A1 | The use of mammalian liver extract for the manufacture of a medicament to treat presenile or senile dementia | KREMERS- URBAN CO. (US) | 1993-08-11 | — | — | EP | disclosed |
| EP-0537722-A2 | Porcane liver polypeptides for treating viral infections | KREMERS- URBAN CO. (US) | 1993-04-21 | — | — | EP | disclosed |